Harmony Biosciences's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Harmony Biosciences (NASDAQ:HRMY) is set to release its latest quarterly earnings report on October 31, 2023. Analysts estimate an earnings per share (EPS) of $0.65. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $19.2, down 66.81% over the last 52-week period.
October 30, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Harmony Biosciences is expected to report an EPS of $0.65 in its upcoming earnings. The company's past earnings have had a mixed impact on its share price. The stock is currently down 66.81% over the last 52 weeks.
The upcoming earnings report is highly relevant to Harmony Biosciences as it could influence the stock's performance. However, the company's past earnings have shown a mixed impact on the share price, making it difficult to predict the short-term impact of the upcoming earnings report. The stock's significant decline over the past year indicates a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100